Fulgent Genetics, Inc. — Director's Dealing 2020

Dec 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-12-09

Reporting Person: KIM PAUL (CFO and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-09	Common Stock	S	10662	$51.6028	Disposed	191521	Direct
2020-12-10	Common Stock	S	16958	$51.9362	Disposed	174563	Direct

Footnotes

F1: The shares were sold in multiple transactions at prices ranging from $51.5304 to $51.8381, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: The shares were sold in multiple transactions at prices ranging from $51.1481 to $53.0501, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.